Endometrial cancer (EC) is a common gynecological cancer worldwide. Treatment has been improved in recent years; however, in advanced stages, therapeutic options are still limited. The expression of galectins is increased in several tumor types and that they are involved in important cell processes.
View Article and Find Full Text PDFAs many contaminated agricultural soils can no longer be used for food crops, lignocellulosic energy crops matter due to their ability to grow on such soils and to produce biomass for biosourced materials and biofuels, thereby reducing the pressure on the limited arable lands. Sorghum bicolor (L.) Moench, can potentially produce a high biomass suitable for producing bioethanol, renewable gasoline, diesel, and sustainable aircraft fuel, despite adverse environmental conditions (e.
View Article and Find Full Text PDFWhile the establishment of an ovarian cancer biobank from patient-derived organoids along with their clinical background information promises advances in research and patient care, standardization remains a challenge due to the heterogeneity of this lethal malignancy, combined with the inherent complexity of organoid technology. This adaptable protocol provides a systematic framework to realize the full potential of ovarian cancer organoids considering a patient-specific variability of progenitors. By implementing a structured experimental workflow to select optimal culture conditions and seeding methods, with parallel testing of direct 3D seeding versus a 2D/3D route, we obtain, in most cases, robust long-term expanding lines suitable for a broad range of downstream applications.
View Article and Find Full Text PDFAdvances in molecular tumor diagnostics have transformed cancer care. However, it remains unclear whether precision oncology has the same impact and transformative nature across all malignancies. We conducted a retrospective analysis of patients with human papillomavirus (HPV)-related gynecologic malignancies who underwent comprehensive molecular profiling and subsequent discussion at the interdisciplinary Molecular Tumor Board (MTB) of the University Hospital, LMU Munich, between 11/2017 and 06/2022.
View Article and Find Full Text PDF